Centrient Pharmaceuticals, which specializes in creating environmentally-friendly bulk drugs, has ramped up its legal fight to protect what the company calls its “unique, patented enzymatic” antibiotics technology from alleged patent infringement by an Indian firm.
Netherlands-based company Centrient has slapped Dalas Biotech with a second lawsuit accusing the Indian company of infringing the patent on...






